Morrison Foerster represented CMIC HOLDINGS on its strategic capital alliance in respect of CMIC Co., Ltd., Japan’s leading clinical research organization (CRO), with funds managed by Blackstone.
CMIC HOLDINGS and Blackstone will hold a 40% and 60% stake respectively in the business conducted by CMIC Co., Ltd. The transaction is expected to close in May 2025.
The MoFo team advising CMIC HOLDINGS was led by Tokyo corporate partner Nozomi Oda, with support from Tokyo corporate of counsel Takaki Sato and Tokyo corporate associate Ganesh Vaheisvaran.